
Opinion|Videos|January 13, 2025
Symptom Management Agents for Patients with Alzheimer’s Disease
Advertisement
Episodes in this series

Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
From the Field: Neurologist-Written Insights From 2025
2
NeurologyLive® Year in Review 2025: Notable Trials Beginning This Year
3
Remyelinating Agent PIPE-307 Falls Short in Phase 2 Trial of Relapsing Multiple Sclerosis
4
Brain-Penetrant Molecule GT-02287 Demonstrates Reversal of Glucosylsphinogosine in Parkinson Disease
5


























